Associating liver partition and portal vein ligation for staged hepatectomy in patients with colorectal liver metastases--Intermediate oncological results.

[1]  B. Isaksson,et al.  Scandinavian multicenter study on the safety and feasibility of the associating liver partition and portal vein ligation for staged hepatectomy procedure. , 2016, Surgery.

[2]  M. Fakih Metastatic colorectal cancer: current state and future directions. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  V. Ardiles,et al.  Associating liver partition and portal vein ligation for staged hepatectomy offers high oncological feasibility with adequate patient safety: a prospective study at a single center. , 2015, Annals of surgery.

[4]  K. Bertens,et al.  Can we improve the morbidity and mortality associated with the associating liver partition with portal vein ligation for staged hepatectomy (ALPPS) procedure in the management of colorectal liver metastases? , 2015, Surgery.

[5]  D. Raptis,et al.  Early Survival and Safety of ALPPS: First Report of the International ALPPS Registry , 2014, Annals of surgery.

[6]  P. Parrilla,et al.  Tourniquet modification of the associating liver partition and portal ligation for staged hepatectomy procedure , 2014, The British journal of surgery.

[7]  M. Donati,et al.  ALPPS for Patients with Colorectal Liver Metastases: Effective Liver Hypertrophy, but Early Tumor Recurrence , 2014, World Journal of Surgery.

[8]  B. Björnsson,et al.  In Situ Split of the Liver When Portal Venous Embolization Fails to Induce Hypertrophy: A Report of Two Cases , 2013, Case reports in surgery.

[9]  M. Hollands,et al.  A systematic review of two-stage hepatectomy in patients with initially unresectable colorectal liver metastases. , 2013, HPB : the official journal of the International Hepato Pancreato Biliary Association.

[10]  P. Bachellier,et al.  Right portal vein ligation combined with in situ splitting induces rapid left lateral liver lobe hypertrophy enabling 2-staged extended right hepatic resection in small-for-size settings. , 2012, Annals of surgery.

[11]  H. Schlitt,et al.  Right Portal Vein Ligation Combined With In Situ Splitting Induces Rapid Left Lateral Liver Lobe Hypertrophy Enabling 2-Staged Extended Right Hepatic Resection in Small-for-Size Settings , 2012, Annals of surgery.

[12]  S. Curley,et al.  High survival rate after two-stage resection of advanced colorectal liver metastases: response-based selection and complete resection define outcome. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  M. Choti,et al.  Two-stage strategy for patients with extensive bilateral colorectal liver metastases. , 2010, HPB : the official journal of the International Hepato Pancreato Biliary Association.

[14]  H. Bismuth,et al.  Long-Term Results of Two-Stage Hepatectomy for Irresectable Colorectal Cancer Liver Metastases , 2008, Annals of surgery.

[15]  E. Abdalla,et al.  Improving Resectability of Hepatic Colorectal Metastases: Expert Consensus Statement , 2006, Annals of Surgical Oncology.

[16]  N. Demartines,et al.  Classification of Surgical Complications: A New Proposal With Evaluation in a Cohort of 6336 Patients and Results of a Survey , 2004, Annals of Surgery.

[17]  Roland Materne,et al.  Body surface area and body weight predict total liver volume in Western adults , 2002, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[18]  M Schemper,et al.  A note on quantifying follow-up in studies of failure time. , 1996, Controlled clinical trials.

[19]  J. Faivre,et al.  Prospective study of prognostic factors in patients with unresected hepatic metastases from colorectal cancer , 1995, The British journal of surgery.

[20]  W. Helton,et al.  An analytical review of vasculobiliary injury in laparoscopic and open cholecystectomy. , 2011, HPB : the official journal of the International Hepato Pancreato Biliary Association.